Cargando…

Delivery of miR‐3529‐3p using MnO(2)‐SiO(2)‐APTES nanoparticles combined with phototherapy suppresses lung adenocarcinoma progression by targeting HIGD1A

BACKGROUND: The present study aimed to investigate the function of miR‐3529‐3p in lung adenocarcinoma and MnO(2)‐SiO(2)‐APTES (MSA) as a promising multifunctional delivery agent for lung adenocarcinoma therapy. METHODS: Expression levels of miR‐3529‐3p were evaluated in lung carcinoma cells and tiss...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ying, Wang, Ran‐Ran, Liu, Rui, Xie, Shu‐Yang, Jiao, Fei, Li, You‐Jie, Xin, Jiaxuan, Zhang, Han, Wang, Zhenbo, Yan, Yun‐Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067359/
https://www.ncbi.nlm.nih.gov/pubmed/36808485
http://dx.doi.org/10.1111/1759-7714.14823
_version_ 1785018447508275200
author Zhang, Ying
Wang, Ran‐Ran
Liu, Rui
Xie, Shu‐Yang
Jiao, Fei
Li, You‐Jie
Xin, Jiaxuan
Zhang, Han
Wang, Zhenbo
Yan, Yun‐Fei
author_facet Zhang, Ying
Wang, Ran‐Ran
Liu, Rui
Xie, Shu‐Yang
Jiao, Fei
Li, You‐Jie
Xin, Jiaxuan
Zhang, Han
Wang, Zhenbo
Yan, Yun‐Fei
author_sort Zhang, Ying
collection PubMed
description BACKGROUND: The present study aimed to investigate the function of miR‐3529‐3p in lung adenocarcinoma and MnO(2)‐SiO(2)‐APTES (MSA) as a promising multifunctional delivery agent for lung adenocarcinoma therapy. METHODS: Expression levels of miR‐3529‐3p were evaluated in lung carcinoma cells and tissues by qRT‐PCR. The effects of miR‐3529‐3p on apoptosis, proliferation, metastasis and neovascularization were assessed by CCK‐8, FACS, transwell and wound healing assays, tube formation and xenografts experiments. Luciferase reporter assays, western blot, qRT‐PCR and mitochondrial complex assay were used to determine the targeting relationship between miR‐3529‐3p and hypoxia‐inducible gene domain family member 1A (HIGD1A). MSA was fabricated using MnO(2) nanoflowers, and its heating curves, temperature curves, IC50, and delivery efficiency were examined. The hypoxia and reactive oxygen species (ROS) production was investigated by nitro reductase probing, DCFH‐DA staining and FACS. RESULTS: MiR‐3529‐3p expression was reduced in lung carcinoma tissues and cells. Transfection of miR‐3529‐3p could promote apoptosis and suppress cell proliferation, migration and angiogenesis. As a target of miR‐3529‐3p, HIGD1A expression was downregulated, through which miR‐3529‐3p could disrupt the activities of complexes III and IV of the respiratory chain. The multifunctional nanoparticle MSA could not only efficiently deliver miR‐3529‐3p into cells, but also enhance the antitumor function of miR‐3529‐3p. The underlying mechanism may be that MSA alleviates hypoxia and has synergistic effects in cellular ROS promotion with miR‐3529‐3p. CONCLUSIONS: Our results establish the antioncogenic role of miR‐3529‐3p, and demonstrate that miR‐3529‐3p delivered by MSA has enhanced tumor suppressive effects, probably through elevating ROS production and thermogenesis.
format Online
Article
Text
id pubmed-10067359
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-100673592023-04-04 Delivery of miR‐3529‐3p using MnO(2)‐SiO(2)‐APTES nanoparticles combined with phototherapy suppresses lung adenocarcinoma progression by targeting HIGD1A Zhang, Ying Wang, Ran‐Ran Liu, Rui Xie, Shu‐Yang Jiao, Fei Li, You‐Jie Xin, Jiaxuan Zhang, Han Wang, Zhenbo Yan, Yun‐Fei Thorac Cancer Original Articles BACKGROUND: The present study aimed to investigate the function of miR‐3529‐3p in lung adenocarcinoma and MnO(2)‐SiO(2)‐APTES (MSA) as a promising multifunctional delivery agent for lung adenocarcinoma therapy. METHODS: Expression levels of miR‐3529‐3p were evaluated in lung carcinoma cells and tissues by qRT‐PCR. The effects of miR‐3529‐3p on apoptosis, proliferation, metastasis and neovascularization were assessed by CCK‐8, FACS, transwell and wound healing assays, tube formation and xenografts experiments. Luciferase reporter assays, western blot, qRT‐PCR and mitochondrial complex assay were used to determine the targeting relationship between miR‐3529‐3p and hypoxia‐inducible gene domain family member 1A (HIGD1A). MSA was fabricated using MnO(2) nanoflowers, and its heating curves, temperature curves, IC50, and delivery efficiency were examined. The hypoxia and reactive oxygen species (ROS) production was investigated by nitro reductase probing, DCFH‐DA staining and FACS. RESULTS: MiR‐3529‐3p expression was reduced in lung carcinoma tissues and cells. Transfection of miR‐3529‐3p could promote apoptosis and suppress cell proliferation, migration and angiogenesis. As a target of miR‐3529‐3p, HIGD1A expression was downregulated, through which miR‐3529‐3p could disrupt the activities of complexes III and IV of the respiratory chain. The multifunctional nanoparticle MSA could not only efficiently deliver miR‐3529‐3p into cells, but also enhance the antitumor function of miR‐3529‐3p. The underlying mechanism may be that MSA alleviates hypoxia and has synergistic effects in cellular ROS promotion with miR‐3529‐3p. CONCLUSIONS: Our results establish the antioncogenic role of miR‐3529‐3p, and demonstrate that miR‐3529‐3p delivered by MSA has enhanced tumor suppressive effects, probably through elevating ROS production and thermogenesis. John Wiley & Sons Australia, Ltd 2023-02-20 /pmc/articles/PMC10067359/ /pubmed/36808485 http://dx.doi.org/10.1111/1759-7714.14823 Text en © 2023 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Zhang, Ying
Wang, Ran‐Ran
Liu, Rui
Xie, Shu‐Yang
Jiao, Fei
Li, You‐Jie
Xin, Jiaxuan
Zhang, Han
Wang, Zhenbo
Yan, Yun‐Fei
Delivery of miR‐3529‐3p using MnO(2)‐SiO(2)‐APTES nanoparticles combined with phototherapy suppresses lung adenocarcinoma progression by targeting HIGD1A
title Delivery of miR‐3529‐3p using MnO(2)‐SiO(2)‐APTES nanoparticles combined with phototherapy suppresses lung adenocarcinoma progression by targeting HIGD1A
title_full Delivery of miR‐3529‐3p using MnO(2)‐SiO(2)‐APTES nanoparticles combined with phototherapy suppresses lung adenocarcinoma progression by targeting HIGD1A
title_fullStr Delivery of miR‐3529‐3p using MnO(2)‐SiO(2)‐APTES nanoparticles combined with phototherapy suppresses lung adenocarcinoma progression by targeting HIGD1A
title_full_unstemmed Delivery of miR‐3529‐3p using MnO(2)‐SiO(2)‐APTES nanoparticles combined with phototherapy suppresses lung adenocarcinoma progression by targeting HIGD1A
title_short Delivery of miR‐3529‐3p using MnO(2)‐SiO(2)‐APTES nanoparticles combined with phototherapy suppresses lung adenocarcinoma progression by targeting HIGD1A
title_sort delivery of mir‐3529‐3p using mno(2)‐sio(2)‐aptes nanoparticles combined with phototherapy suppresses lung adenocarcinoma progression by targeting higd1a
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067359/
https://www.ncbi.nlm.nih.gov/pubmed/36808485
http://dx.doi.org/10.1111/1759-7714.14823
work_keys_str_mv AT zhangying deliveryofmir35293pusingmno2sio2aptesnanoparticlescombinedwithphototherapysuppresseslungadenocarcinomaprogressionbytargetinghigd1a
AT wangranran deliveryofmir35293pusingmno2sio2aptesnanoparticlescombinedwithphototherapysuppresseslungadenocarcinomaprogressionbytargetinghigd1a
AT liurui deliveryofmir35293pusingmno2sio2aptesnanoparticlescombinedwithphototherapysuppresseslungadenocarcinomaprogressionbytargetinghigd1a
AT xieshuyang deliveryofmir35293pusingmno2sio2aptesnanoparticlescombinedwithphototherapysuppresseslungadenocarcinomaprogressionbytargetinghigd1a
AT jiaofei deliveryofmir35293pusingmno2sio2aptesnanoparticlescombinedwithphototherapysuppresseslungadenocarcinomaprogressionbytargetinghigd1a
AT liyoujie deliveryofmir35293pusingmno2sio2aptesnanoparticlescombinedwithphototherapysuppresseslungadenocarcinomaprogressionbytargetinghigd1a
AT xinjiaxuan deliveryofmir35293pusingmno2sio2aptesnanoparticlescombinedwithphototherapysuppresseslungadenocarcinomaprogressionbytargetinghigd1a
AT zhanghan deliveryofmir35293pusingmno2sio2aptesnanoparticlescombinedwithphototherapysuppresseslungadenocarcinomaprogressionbytargetinghigd1a
AT wangzhenbo deliveryofmir35293pusingmno2sio2aptesnanoparticlescombinedwithphototherapysuppresseslungadenocarcinomaprogressionbytargetinghigd1a
AT yanyunfei deliveryofmir35293pusingmno2sio2aptesnanoparticlescombinedwithphototherapysuppresseslungadenocarcinomaprogressionbytargetinghigd1a